Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 193084, 8 pages
http://dx.doi.org/10.1155/2013/193084
Research Article

Bai-Hu-Tang, Ancient Chinese Medicine Formula, May Provide a New Complementary Treatment Option for Sepsis

1Department of Chinese Medicine, National Defense Medical Center, Tri-Service General Hospital, Taipei 11490, Taiwan
2Graduate Institute of Chinese Medicine, College of Chinese Medicine, China Medical University, No. 91 Hsueh-Shih Road, Taichung 40402, Taiwan
3School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan
4Graduate Institute of Biostatistics, College of Public Health, China Medical University, Taichung 40402, Taiwan
5Department of Healthcare Administration, College of Health Science, Asia University, Taichung 41354, Taiwan

Received 7 January 2013; Revised 19 April 2013; Accepted 25 April 2013

Academic Editor: Martin Kohlmeier

Copyright © 2013 Chien-Jung Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Butler, “Translational research: crossing the valley of death,” Nature, vol. 453, no. 7197, pp. 840–842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Woolf, “The meaning of translational research and why it matters,” Journal of the American Medical Association, vol. 299, no. 2, pp. 211–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Google Scholar · View at Scopus
  4. J. L. Vincent, Y. Sakr, C. L. Sprung et al., “Sepsis in European intensive care units: results of the SOAP study,” Critical Care Medicine, vol. 34, no. 2, pp. 344–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Russell, “Management of sepsis,” The New England Journal of Medicine, vol. 355, no. 16, pp. 1699–1713, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Carlet, “Prescribing indications based on successful clinical trials in sepsis: a difficult exercise,” Critical Care Medicine, vol. 34, no. 2, pp. 525–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Glauser, “Pathophysiologic basis of sepsis: considerations for future strategies of intervention,” Critical Care Medicine, vol. 28, no. 9, pp. S4–S8, 2000. View at Google Scholar · View at Scopus
  8. L. Liaudet, J. G. Mabley, F. G. Soriano et al., “Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 7, pp. 1213–1220, 2001. View at Google Scholar · View at Scopus
  9. M. W. N. Nijsten, C. E. Hack, M. Helle, H. J. ten Duis, H. J. Klasen, and L. A. Aarden, “Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients,” Surgery, vol. 109, no. 6, pp. 761–767, 1991. View at Google Scholar · View at Scopus
  10. O. Murch, M. Abdelrahman, M. Collino et al., “Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat,” Critical Care Medicine, vol. 36, no. 2, pp. 550–559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. van den Berghe, P. Wouters, F. Weekers et al., “Intensive insulin therapy in critically ill patients,” The New England Journal of Medicine, vol. 345, no. 19, pp. 1359–1367, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. F. L. Yeh, H. D. Shen, and R. H. Fang, “Deficient transforming growth factor β and interleukin-10 responses contribute to the septic death of burned patients,” Burns, vol. 28, no. 7, pp. 631–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. R. C. Bone, “Sir Isaac Newton, sepsis, SIRS, and CARS,” Critical Care Medicine, vol. 24, no. 7, pp. 1125–1128, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. R. C. Bone, C. J. Grodzin, and R. A. Balk, “Sepsis: a new hypothesis for pathogenesis of the disease process,” Chest, vol. 112, no. 1, pp. 235–243, 1997. View at Google Scholar · View at Scopus
  15. J. A. Kellum, L. Kong, M. P. Fink et al., “Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study,” Archives of Internal Medicine, vol. 167, no. 15, pp. 1655–1663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. X. C. Xu, Pharmacology of Traditional Chinese Medical Formulae, Higher Educational Press, Beijing, China, 1994.
  17. C. Y. Liu, A. Tseng, and Y. Sue, Chinese Herbal Medicine: Modern Applications of Traditional Formulas, CRC Press, New York, NY, USA, 2005.
  18. G. Maciocia, The Foundations of Chinese Medicine: A Comprehensive Text for Acupuncturists and Herbalists, Elsevier Churchill Livingstone, Edinburgh, UK, 2005.
  19. C. H. Wang, M. J. Gee, C. Yang, and Y. C. Su, “A new model for outcome prediction in intra-abdominal sepsis by the linear discriminant function analysis of IL-6 and IL-10 at different heart rates,” Journal of Surgical Research, vol. 132, no. 1, pp. 46–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Wichterman, A. E. Baue, and I. H. Chaudry, “Sepsis and septic shock: a review of laboratory models and a proposal,” Journal of Surgical Research, vol. 29, no. 2, pp. 189–201, 1980. View at Google Scholar · View at Scopus
  21. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Critical Care Medicine, vol. 36, no. 1, pp. 296–327, 2008. View at Google Scholar
  22. D. Vyas, P. Javadi, P. J. Dipasco, T. G. Buchman, R. S. Hotchkiss, and C. M. Coopersmith, “Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels,” American Journal of Physiology, vol. 289, no. 4, pp. R1048–R1053, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. P. Rim, K. Kim, Y. H. Jo et al., “Effect of therapeutic hypothermia according to severity of sepsis in a septic rat model,” Cytokine, vol. 60, no. 3, pp. 755–761, 2012. View at Google Scholar
  24. J. L. D. Souza Neto, I. Araújo Filho, A. C. M. Do Rego et al., “Effects of simvastatin in abdominal sepsis in rats,” Acta Cirurgica Brasileira, vol. 21, supplement 4, pp. 8–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Carlet, J. Cohen, T. Calandra, S. M. Opal, and H. Masur, “Sepsis: time to reconsider the concept,” Critical Care Medicine, vol. 36, no. 3, pp. 964–966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Finnerty, D. N. Herndon, D. L. Chinkes, and M. G. Jeschke, “Serum cytokine differences in severely burned children with and without sepsis,” Shock, vol. 27, no. 1, pp. 4–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Y. Peng, M. J. Carter, and J. A. Kellum, “Effects of hemoadsorption on cytokine removal and short-term survival in septic rats,” Critical Care Medicine, vol. 36, no. 5, pp. 1573–1577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Echtenacher, W. Falk, D. N. Mannel, and P. H. Krammer, “Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis,” Journal of Immunology, vol. 145, no. 11, pp. 3762–3766, 1990. View at Google Scholar · View at Scopus
  29. M. K. Eskandari, G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick, “Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia,” Journal of Immunology, vol. 148, no. 9, pp. 2724–2730, 1992. View at Google Scholar · View at Scopus
  30. C. S. Deutschman, M. Cereda, E. A. Ochroch, and N. R. Raj, “Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6 -/- mice,” Critical Care Medicine, vol. 34, no. 10, pp. 2613–2620, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Oberholzer, C. Oberholzer, and L. L. Moldawer, “Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug,” Critical Care Medicine, vol. 30, supplement 1, pp. S58–S63, 2002. View at Google Scholar · View at Scopus
  32. D. G. Remick, G. R. Bolgos, J. Siddiqui, J. Shin, and J. A. Nemzek, “Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days,” Shock, vol. 17, no. 6, pp. 463–467, 2002. View at Google Scholar · View at Scopus